Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.
J Immunother Cancer. 2023 Mar;11(3):e005325. doi: 10.1136/jitc-2022-005325.
J Immunother Cancer. 2023.
PMID: 36889811
Free PMC article.
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.
Mercogliano MF, Bruni S, Mauro F, Elizalde PV, Schillaci R.
Mercogliano MF, et al.
Cancers (Basel). 2021 Feb 2;13(3):564. doi: 10.3390/cancers13030564.
Cancers (Basel). 2021.
PMID: 33540543
Free PMC article.
Review.
Item in Clipboard
Emerging Targeted Therapies for HER2-Positive Breast Cancer.
Mercogliano MF, Bruni S, Mauro FL, Schillaci R.
Mercogliano MF, et al. Among authors: mauro fl.
Cancers (Basel). 2023 Mar 26;15(7):1987. doi: 10.3390/cancers15071987.
Cancers (Basel). 2023.
PMID: 37046648
Free PMC article.
Review.
Item in Clipboard
Cancer immune exclusion: breaking the barricade for a successful immunotherapy.
Bruni S, Mercogliano MF, Mauro FL, Cordo Russo RI, Schillaci R.
Bruni S, et al. Among authors: mauro fl.
Front Oncol. 2023 May 22;13:1135456. doi: 10.3389/fonc.2023.1135456. eCollection 2023.
Front Oncol. 2023.
PMID: 37284199
Free PMC article.
Review.
Item in Clipboard
Cite
Cite